Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Stress can trigger or worsen alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

More severe alopecia areata can lower quality of life.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Male gender and family history predict alopecia areata recurrence.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Oxidative stress is linked to mild patchy alopecia areata.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Giant cells found in some male pattern baldness cases may help diagnose it and suggest hair is mistakenly seen as foreign by the body.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.